"We think that the prices it sets in the market, and which are characterized by excessive greed and excessive profit, are denying life to the neediest people, the populations most vulnerable to illnesses such as HIV,"
Gilead, he said, uses its control of patents "to obstruct the availability of these medications in medium- and low-income countries."
Matus pointed to the prices of Covid-19 drug Remdesivir,
Median household income in
The head of Programs at AHF Mexico,
Developing countries generally have a fixed budget for buying medicine "and the Mexican government has to buy few medications because they are unaffordable," he told EFE.
Bustamante said Gilead has an obligation to justify the exorbitant prices it demands for life-saving and life-sustaining drugs.
AHF accepts the right of Gilead and other pharmaceutical companies to make profits, Matus said.
"We know that it takes time to develop a molecule for a medication, but Gilead doesn't want to drop their prices," he said. "The profit is excessive and occasionally reaches incredible proportions of up to 200 percent." EFE csr/dr
© 2023 EFE News Services (U.S.) Inc., source